Σύγκριση μεθόδων

	Ερωτηματολόγιο Ελέγχου Άσθματος	Ερωτηματολόγιο Ποιότητας Ζωής Ρινοεπιπεφυκίτιδας
Πεδίο	Πνευμονολογία	Πνευμονολογία
Οικογένεια	Process / pipeline	Process / pipeline
Έτος προέλευσης	1999	1996
Δημιουργός	Elizabeth F. Juniper, McMaster University	Elizabeth F. Juniper, McMaster University
Τύπος	Self-report questionnaire	Self-report questionnaire
Θεμελιώδης πηγή	Juniper, E. F., O'Byrne, P. M., Guyatt, G. H., Ferrie, P. J., & King, D. R. (1999). Development and validation of a questionnaire to measure asthma control. European Respiratory Journal, 14(4), 902-907.	Juniper, E. F., Guyatt, G. H., Streiner, D. L., & King, D. R. (1996). Clinical validation and responsiveness of three scales developed to measure the effect of allergic rhinitis on quality of life. Journal of Clinical Epidemiology, 49(3), 339-347.
Εναλλακτικές ονομασίες	ACQ, Asthma Control Q	RQLQ, Rhinoconjunctivitis QoL
Συναφείς	5	5
Σύνοψη	The ACQ is a 7-item self-report questionnaire developed by Juniper and colleagues at McMaster University in 1999 to assess the degree of asthma control in the previous one to two weeks. Unlike generic respiratory tools, the ACQ measures symptom-based control and rescue medication use, providing a simple yet psychometrically sound method for evaluating treatment efficacy. It is widely adopted in clinical trials, guideline-driven care, and routine asthma management to guide therapy titration and assess treatment response.	The RQLQ is a 28-item disease-specific quality-of-life instrument developed by Juniper and colleagues at McMaster University in 1996 to assess the impact of allergic rhinitis and allergic conjunctivitis on daily functioning. It captures symptom burden and activity limitation across seven domains: sleep, non-nose/eye symptoms, practical problems, nasal symptoms, eye symptoms, activity limitation, and emotional function. The RQLQ is the preferred outcome measure in allergic rhinitis clinical trials and is widely used in allergy and immunology practice to track treatment response.